To detect the critical factors underlying mucus dysfunction in IBD, we performed single-cell analysis and discovered that serine protease inhibitor Kazal-type 4 (SPINK4), a noteless participant in the serine protease inhibitor family, was dynamically regulated in colitic intestine. This evidence concerns the gene SPINK4 and inflammatory bowel disease.